- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 209/14 - Radicals substituted by nitrogen atoms, not forming part of a nitro radical
Patent holdings for IPC class C07D 209/14
Total number of patents in this class: 826
10-year publication summary
|
72
|
44
|
64
|
43
|
44
|
50
|
54
|
44
|
28
|
25
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Achillion Pharmaceuticals, Inc. | 157 |
23 |
| Katholieke Universiteit Leuven | 1283 |
21 |
| Generics [UK] Limited | 108 |
20 |
| Janssen Pharmaceuticals, Inc. | 435 |
17 |
| Novartis AG | 10262 |
10 |
| Adeka Corporation | 1377 |
10 |
| Pacific Biosciences of California, Inc. | 712 |
10 |
| Redwood BioScience, Inc. | 30 |
9 |
| PMV Pharmaceuticals, Inc. | 50 |
9 |
| The Johns Hopkins University | 5882 |
8 |
| The Board of Trustees of the University of Illinois | 2751 |
8 |
| Korea University Research and Business Foundation | 3266 |
8 |
| Mylan Development Centre Private Limited | 12 |
8 |
| Rutgers, The State University of New Jersey | 1973 |
8 |
| Caamtech, Inc. | 152 |
8 |
| The Regents of the University of California | 20745 |
7 |
| Life Technologies Corporation | 3458 |
7 |
| Neoculi Pty Ltd | 18 |
7 |
| The General Hospital Corporation | 4870 |
6 |
| Bristol-myers Squibb Company | 4742 |
5 |
| Other owners | 617 |